Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Apeptico Forschung und Entwicklung GmbH
ClinicalTrials.gov Identifier:
NCT01627613
First received: June 20, 2012
Last updated: March 20, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)